R(+) Pramipexole Dihydrochloride Monohydrate

pramipexole dihydrochloride monohydrate (R(+) enantiomer)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R(+) Pramipexole Dihydrochloride Monohydrate, covering 2012-07-25 to 2012-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day